Find Mephentermine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Mephenterdrine, Mefenterdrin, Mephenterdrinum, Mephetedrine, Mefentermin, Vialin
Molecular Formula
C11H17N
Molecular Weight
163.26  g/mol
InChI Key
RXQCGGRTAILOIN-UHFFFAOYSA-N
FDA UNII
TEZ91L71V4

Mephentermine
A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
1 2D Structure

Mephentermine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N,2-dimethyl-1-phenylpropan-2-amine
2.1.2 InChI
InChI=1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3
2.1.3 InChI Key
RXQCGGRTAILOIN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(CC1=CC=CC=C1)NC
2.2 Other Identifiers
2.2.1 UNII
TEZ91L71V4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Mephentermine Sulfate

2. Mephentermine Sulfate (2:1)

3. Sulfate, Mephentermine

2.3.2 Depositor-Supplied Synonyms

1. Mephenterdrine

2. Mefenterdrin

3. Mephenterdrinum

4. Mephetedrine

5. Mefentermin

6. Vialin

7. N-methylphentermine

8. 100-92-5

9. Wyfentermina

10. Mephine

11. Wyamine

12. N,2-dimethyl-1-phenylpropan-2-amine

13. Mephentermine Sulfate

14. Wy-585

15. 2-methyl-2-methylamino-1-phenylpropane

16. 2-methylamino-2-methyl-1-phenylpropane

17. Mephentermine (inn)

18. N-methyl-omega-phenyl-tert-butylamine

19. Chebi:6755

20. Tez91l71v4

21. Benzeneethanamine, N,.alpha.,.alpha.-trimethyl-

22. Mefentermina

23. Mephenterminum

24. N,.alpha.,.alpha.-trimethylphenethylamine

25. Methyl(2-methyl-1-phenylpropan-2-yl)amine

26. Mephentermine Sodium

27. Phenethylamine, N,.alpha.,.alpha.-trimethyl-

28. Mephentermine [inn]

29. Mephentermine [inn:ban]

30. Mefentermina [inn-spanish]

31. Mephenterminum [inn-latin]

32. N,2-dimethyl-1-phenylpropan-2-amine;n,2-dimethyl-1-phenylpropan-2-amine

33. N-methyl-omega-phenyl-t-butylamine

34. Omega-phenyl-tert-butyl-methylamine

35. N,alpha,alpha-trimethylphenethylamine

36. N,alpha,alpha-trimethylbenzeneethanamine

37. Hsdb 2172

38. Benzeneethanamine, N,alpha,alpha-trimethyl-

39. Ncgc00016570-01

40. Einecs 202-901-6

41. Cas-1212-72-2

42. Brn 1363850

43. Unii-tez91l71v4

44. Phenethylamine, N,alpha,alpha-trimethyl-

45. Fentermin (salt/mix)

46. (1,1-dimethyl-2-phenylethyl)methylamine

47. Spectrum_001611

48. Prestwick0_000726

49. Prestwick1_000726

50. Prestwick2_000726

51. Prestwick3_000726

52. Spectrum2_000474

53. Spectrum3_001220

54. Spectrum4_000188

55. Spectrum5_001008

56. Mephentermine [mi]

57. Mephentermine [hsdb]

58. Bspbio_000652

59. Bspbio_002640

60. Kbiogr_000735

61. Kbioss_002091

62. Mephentermine [vandf]

63. Divk1c_000229

64. Schembl121178

65. Spbio_000608

66. Spbio_002591

67. Mephentermine [who-dd]

68. Bpbio1_000718

69. Gtpl7222

70. Chembl1201234

71. Dtxsid4023256

72. Bdbm81455

73. Kbio1_000229

74. Kbio2_002091

75. Kbio2_004659

76. Kbio2_007227

77. Kbio3_002140

78. Ninds_000229

79. Cas_3677

80. Nsc_3677

81. Zinc8132748

82. .omega.-phenyl-tert-butyl-methylamine

83. N-methyl-.omega.-phenyl-t-butylamine

84. Akos006281398

85. Db01365

86. Idi1_000229

87. N,2-dimethyl-1-phenyl-2-propanamine #

88. N-methyl-.omega.-phenyl-tert-butylamine

89. Ncgc00016570-02

90. Ncgc00016570-03

91. Sbi-0051802.p002

92. Ab00053662

93. N,.alpha.,.alpha.-trimethylbenzeneethanamine

94. C07889

95. D08180

96. Ab00053662_08

97. 100m925

98. N,.alpha.,.alpha.-trimethyl-.beta.-phenethylamine

99. Q6817800

100. Brd-k18194590-065-05-6

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 163.26 g/mol
Molecular Formula C11H17N
XLogP32.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count3
Exact Mass163.136099547 g/mol
Monoisotopic Mass163.136099547 g/mol
Topological Polar Surface Area12 Ų
Heavy Atom Count12
Formal Charge0
Complexity123
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Adrenergic alpha-Agonists; Adrenergic Agents; Sympathomimetics; Vasoconstrictor Agents

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


Mephentermine ... is used to prevent hypotension, which frequently accompanies spinal anesthesia.

Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 217


IT IS NOT RECOMMENDED FOR ROUTINE USE IN MANAGEMENT OF SHOCK, ESPECIALLY HYPOVOLEMIC SHOCK, ALTHOUGH IT CAN BE GIVEN AS INTERIM DRUG WHILE PREPARATIONS ARE BEING MADE FOR FLUID REPLACEMENT & OTHER MEASURES. /SULFATE/

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 169


...FREE BASE CAN BE EMPLOYED TOPICALLY AS MYDRIATIC.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 816


For more Therapeutic Uses (Complete) data for MEPHENTERMINE (9 total), please visit the HSDB record page.


4.2 Drug Warning

Mephentermine may produce arrhythmias, including extrasystoles, and AV block and hypertension. Arrhythmias are most likely to occur in patients with heart disease or those receiving other drugs which may increase cardiac irritability such as cyclopropane or halogenated hydrocarbon general anesthetics. /Mephentermine sulfate/

McEvoy G.K. (ed.). American Hospital Formulary Service-Drug Information 96. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 1996 (Plus Supplements)., p. 888


The CNS stimulating effects of mephentermine may result in nervousness, anxiety, seizures, or tachycardia. Large overdosage of the drug has caused visual hallucinations of colored geometric forms, paranoid psychosis, and euphoria. Drowsiness, weeping, incoherence, weakness, numbness, and tingling of the extremities have been reported. Withdrawal of the drug results in rapid disappearance of adverse CNS effects. /Mephentermine sulfate/

McEvoy G.K. (ed.). American Hospital Formulary Service-Drug Information 96. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 1996 (Plus Supplements)., p. 888


AS THE FREE BASE IS CURRENTLY USED, UNTOWARD EFFECTS ARE VERY UNCOMMON.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 816


MEPHENTERMINE MAY INCR UTERINE CONTRACTIONS ESPECIALLY DURING THE THIRD TRIMESTER OF PREGNANCY &, THEREFORE, SHOULD NOT BE USED IN PREGNANT WOMEN UNLESS THE POTENTIAL BENEFITS OUTWEIGH THE POSSIBLE RISKS. /MEPHENTERMINE SULFATE/

McEvoy G.K. (ed.). American Hospital Formulary Service-Drug Information 96. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 1996 (Plus Supplements)., p. 889


For more Drug Warnings (Complete) data for MEPHENTERMINE (10 total), please visit the HSDB record page.


4.3 Drug Indication

Used to maintain blood pressure in hypotensive states.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Mephentermine is a sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia. Although the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1248)


5.2 MeSH Pharmacological Classification

Sympathomimetics

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)


Vasoconstrictor Agents

Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)


Adrenergic alpha-1 Receptor Agonists

Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)


5.3 ATC Code

C - Cardiovascular system

C01 - Cardiac therapy

C01C - Cardiac stimulants excl. cardiac glycosides

C01CA - Adrenergic and dopaminergic agents

C01CA11 - Mephentermine


5.4 Absorption, Distribution and Excretion

...MEPHENTERMINE.../IS/ WELL ABSORBED FROM DIGESTIVE TRACT. .../IT/ MAY BE ABSORBED TO A GREATER OR LESSER EXTENT FROM NASAL MUCOSA.

Thienes, C., and T.J. Haley. Clinical Toxicology. 5th ed. Philadelphia: Lea and Febiger, 1972., p. 108


THE MAJORITY OF THE DRUG IS EXCRETED IN THE URINE WITHIN 24 HR. MEPHENTERMINE IS REABSORBED IN THE RENAL TUBULES. EXCRETION OF THE DRUG & ITS METABOLITES IS MORE RAPID IN ACIDIC URINE.

McEvoy G.K. (ed.). American Hospital Formulary Service-Drug Information 96. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 1996 (Plus Supplements)., p. 888


5.5 Metabolism/Metabolites

Hepatic, by N-demethylation and then p-hydroxylation.


MEPHENTERMINE IS METABOLIZED IN THE LIVER BY N-DEMETHYLATION & SUBSEQUENT P-HYDROXYLATION TO NORMEPHENTERMINE & P-HYDROXYNORMEPHENTERMINE. /SULFATE/

McEvoy G.K. (ed.). American Hospital Formulary Service-Drug Information 96. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 1996 (Plus Supplements)., p. 888


MEPHENTERMINE WAS METABOLIZED IN VITRO BY RABBIT LIVER MICROSOMES TO PHENTERMINE (II), N-HYDROXYMEPHENTERMINE (III), & N-HYDROXYPHENTERMINE. METABOLITES (II) & (III) PLUS UNCHANGED MEPHENTERMINE FOUND IN URINE OF HUMAN ADMIN SINGLE DOSE OF MEPHENTERMINE SULFATE.

PMID:2665 BECKETT AH, BELANGER PM; J PHARM PHARMACOL 27 (12): 928 (1975)


Metabolites of mephentermine (MP), phentermine (Ph), p-hydroxy-MP, p-hydroxy-Ph, N-hydroxy-MP and N-hydroxy-Ph on incubation with rat liver microsomal and cytosolic preparations were identified by glc and glc mass spectrometry. Identification of the metabolites indicated the following new metabolic routes of MP: NADPH dependent microsomal formation of p-hydroxy-MP from MP, of p-hydroxy-Ph from p-hydroxy-MP, and the NADH-dependent microsomal formation of Ph from N-hydroxy-Ph.

PMID:1523866 Mori MA, et al; Xenobiotica 22 (4):451-7 (1992)


The urinary excretion of mephentermine (I) and its major metabolite phentermine (II) in human volunteers over a period of several days after oral admin of the drug is described. The total proportion of the drug excreted during 54 hr was 57 to 83%. The ingestion of acetazolamide shortly after admin of I resulted in decr in excretion of both I and II during one day. The administration of furosemide only produced a urinary diluting effect during 2-4 hr after admin.

PMID:16867696 Delbeke FT, Debackers M; J Pharm Biomed Anal 3 (2): 141-8 (1985)


5.6 Biological Half-Life

17 to 18 hours.


17 to 18 hours

USP Convention. USPDI - Drug Information for the Health Care Professional. 16th ed. Volume I. Rockville, MD: U.S. Pharmaceutical Convention, Inc. 1996 (Plus updates)., p. 2743


5.7 Mechanism of Action

Mephentermine is an alpha adrenergic receptor agonist, but also acts indirectly by releasing endogenous norepinephrine. Cardiac output and systolic and diastolic pressures are usually increased. A change in heart rate is variable, depending on the degree of vagal tone. Sometimes the net vascular effect may be vasodilation. Large doses may depress the myocardium or produce central nervous system (CNS) effects.


Mephentermine is a sympathomimetic drug that acts both directly and indirectly; it has many similarities to ephedrine. After an intramuscular injection, the onset of action is prompt (within 5 to 15 minutes), and effects may last for several hours.

Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 216


Since the drug releases norepinephrine, cardiac contraction is enhanced and cardiac output and systolic and diastolic pressures are usually increased. The change in heart rate is variable, depending on the degree of vagal tone.

Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 216


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"MEPHENTERMINE","year":"2021","qtr":"Q1","strtotime":1614537000,"product":"MEPHENTERMINE SULPHATE USP ( IGST LUT N","address":"ACME PLAZA, ANDHERI KURLA ROAD,ANDHERI EAST","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"VIRACOPOS","customer":"ZOETIS","customerCountry":"BRAZIL","quantity":"397.14","actualQuantity":"397.14","unit":"KGS","unitRateFc":"188.8","totalValueFC":"73748.6","currency":"USD","unitRateINR":13519.162008359774,"date":"01-Mar-2021","totalValueINR":"5369000","totalValueInUsd":"73748.6","indian_port":"MADRAS AIR","hs_no":"29420090","bill_no":"9028830","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"MADRAS AIR","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,ANDHERI EAST, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705861800,"product":"SAP CODE:2022855 HARMLESS PHARMACEUTICALBULK DRUG MEPHENTERMINE SULPHATE USP PACK:KG (BATCH NO AS PER INVOICE","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"SANTOS","customer":"M\/S","customerCountry":"BRAZIL","quantity":"700.00","actualQuantity":"700","unit":"KGS","unitRateFc":"190","totalValueFC":"131423","currency":"USD","unitRateINR":15603.9827,"date":"22-Jan-2024","totalValueINR":"10922787.89","totalValueInUsd":"131423","indian_port":"Madras Sea","hs_no":"29214190","bill_no":"6931138","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Madras Sea","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705861800,"product":"SAP CODE : 2022855 HARMLESS PHARMACEUTICAL BULK DRUG MEPHENTERMINE SULPHATE USP","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"VIRACOPOS","customer":"M\/S","customerCountry":"BRAZIL","quantity":"80.00","actualQuantity":"80","unit":"KGS","unitRateFc":"205","totalValueFC":"15684.8","currency":"USD","unitRateINR":16294.90625,"date":"22-Jan-2024","totalValueINR":"1303592.5","totalValueInUsd":"15684.8","indian_port":"Madras Air","hs_no":"29214190","bill_no":"6935327","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Madras Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""}]
01-Mar-2021
22-Jan-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty